TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $356,395 | -10.1% | 126,831 | -2.7% | 0.00% | – |
| Q2 2023 | $396,383 | -81.9% | 130,389 | -88.8% | 0.00% | – |
| Q1 2023 | $2,189,949 | +95.3% | 1,164,867 | +5.9% | 0.00% | – |
| Q4 2022 | $1,121,536 | -78.5% | 1,099,545 | -44.7% | 0.00% | – |
| Q3 2022 | $5,227,000 | -54.0% | 1,987,736 | -21.1% | 0.00% | – |
| Q2 2022 | $11,370,000 | -52.5% | 2,520,605 | +3.6% | 0.00% | -100.0% |
| Q1 2022 | $23,950,000 | -34.6% | 2,433,914 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $36,626,000 | +56.0% | 2,395,465 | +38.3% | 0.00% | 0.0% |
| Q3 2021 | $23,483,000 | -9.8% | 1,731,832 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $26,047,000 | – | 1,773,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |